Search

everythinglearnresearchcommunity

for

Search:↓

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

The document explains how shampoos clean, rinses condition, one-step shampoos offer convenience, and hair growth promoters aim to prevent hair loss, emphasizing the importance of scientific evidence for their effectiveness.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Too much topical minoxidil can cause excessive hair growth, but stopping treatment reverses it.

No definitive link between finasteride and male breast cancer, but further research is needed.

Birth control pills can cause skin issues but may help with acne and hirsutism, and choosing the right type can minimize side effects.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Oestrogens are key for bone growth during puberty in both boys and girls.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.